Iperidon Tablets 3mg (Risperidone)

Adult dose

The therapeutic dose of this medicine should be adjusted according to the patient's clinical condition, and the lowest effective dose possible should be administered. Place this medicine on the tongue and, once it disintegrates within a few seconds, swallow it with or without water (for orally disintegrating tablets only). 1. Schizophrenia 1) Adults (1) Initial dose: Administer 1 mg of risperidone orally twice daily and increase the dose gradually. (2) Maintenance dose: Administer 1∼3 mg twice daily. Adjust the dose appropriately according to age and symptoms. (3) No additional effect was observed with doses of 10 mg or more per day compared with lower doses, and such doses may increase the risk of extrapyramidal symptoms. Doses of 10 mg or more per day should be administered only when the benefits for the individual patient are considered to outweigh the risks. (4) Do not administer doses of 16 mg or more per day, as safety has not been established. (5) A benzodiazepine may be administered concomitantly if an additional sedative effect is needed. 2) Administration in special populations · Elderly patients and patients predisposed to hypotension The initial dose is 0.5 mg twice daily. Depending on the patient's condition, increase the dose by 0.5 mg twice daily until a dose of 1～2 mg twice daily is reached. In general, increases to doses of 1.5 mg or more twice daily should be made at intervals of at least 1 week. 3) Switching from an existing antipsychotic to this medicine When medically appropriate, initiate treatment with this medicine while gradually reducing the dose of the existing medicine. Also, when switching from an existing depot antipsychotic, if medically appropriate, initiate treatment with this medicine in place of the next scheduled injection of the depot formulation. The need to continue concomitant antiparkinsonian medication should be reassessed regularly. 2. Agitation, aggression, or psychotic symptoms in patients with dementia of the Alzheimer's type The initial dose is 0.25 mg of this medicine twice daily. If needed, depending on the patient, the dose may be increased by 0.25 mg twice daily at intervals of at least 2 days. The optimal dose for most patients is 0.5 mg twice daily, but depending on the patient, the dose may be increased to 1 mg twice daily. Once the patient has reached the optimal dose, once-daily dosing may also be considered. As with symptomatic treatment, the appropriateness of continued use of this medicine should be evaluated. 3. Adjunctive treatment of mania in bipolar disorder · The recommended initial dose is 2 mg of this medicine once daily. Depending on the patient, the dose may be increased by 1 mg per day at intervals of at least 24 hours. The optimal dose for most patients is within the range of 2∼6 mg per day. As with symptomatic treatment, the appropriateness of continued use of this medicine should be evaluated. Renal and hepatic impairment In patients with renal or hepatic impairment, administer half the initial and maintenance doses and adjust the dose more gradually. Exercise caution when administering this medicine to these patients (see 5. General Precautions).

Child dose

There is limited clinical experience in children and adolescents under 15 years of age. There is limited clinical experience in children and adolescents under 15 years of age. Body weight 50 kg or more: The initial dose is 0.5 mg of this medicine once daily. If necessary, the dose may be increased by 0.5 mg per day at intervals of at least 2 days. For most patients, the optimal dose is 1 mg once daily. Depending on the patient, 0.5∼1.5 mg may be administered once daily. Body weight less than 50 kg: The initial dose is 0.25 mg once daily. If necessary, the dose may be increased by 0.25 mg per day at intervals of at least 2 days. For most patients, the optimal dose is 0.5 mg once daily. Depending on the patient, 0.25∼0.75 mg may be administered once daily. There is limited clinical experience in children under 5 years of age.

This medication should be used with particular caution in elderly dementia patients, as it may increase mortality. If elderly dementia patients are taking this drug in combination with the diuretic furosemide, the risk of death may be further increased, so the risks and benefits must be carefully considered before co-administration. This medication may increase the risk of thrombosis; therefore, risk factors for thrombosis must be meticulously examined and preventive measures taken before and during use. It contains the artificial sweetener aspartame, which requires caution in patients with phenylketonuria, a genetic disorder, and they must adhere to daily intake limits. Patients with hypersensitivity, central nervous system depression, coma, those receiving epinephrine, and lactose intolerance should not take this medication. Patients with cardiovascular diseases, history of arrhythmias, seizure history, impaired liver or kidney function, suicide risk, patients with Parkinson's disease or Lewy body dementia, diabetes patients, the elderly, and pregnant or breastfeeding women should use this medication with caution. This medication may have various side effects, and drowsiness, dizziness, hypotension, movement disorders, gastrointestinal symptoms, skin rashes have been reported. In particular, elderly dementia patients may experience side effects such as pneumonia, urinary tract infections, confusion, and cerebrovascular accidents more frequently. Weight gain, elevated blood sugar, and a worsening of diabetes may occur during treatment with this medication, so regular monitoring is necessary. Use with other central nervous system depressants or alcohol can enhance central nervous system depressive effects, so caution is needed during co-administration. Additionally, there may be interactions with specific drugs, so it is important to consult with a doctor or pharmacist regarding other medications being taken. Pregnant or breastfeeding women must be cautious, as the use of this medication may affect the fetus or newborn, and it is recommended to discontinue breastfeeding when necessary. In case of overdose, seek immediate medical attention for appropriate treatment, as there is no specific antidote, and symptomatic supportive care is required. This medication should be stored out of reach of children, and it is advisable to take it immediately after opening the package. Additionally, this medication should not be mixed with tea, cola, black tea, etc., and caution is required, especially with liquid preparations, as precipitation may occur.

Increased mortality, cerebrovascular adverse reactions, venous thrombosis, nasopharyngitis, upper respiratory tract infection, sinusitis, urinary tract infection, anemia, hypersensitivity reactions, insomnia, anxiety, neuromuscular irritability, Parkinsonism, akathisia, drowsiness, dizziness, sedation, tremors, muscle tone abnormalities, hypersomnia, orthostatic dizziness, dyskinesia, syncope, blurred vision, ear pain, orthostatic hypotension, tachycardia, hypotension, nasal congestion, dyspnea, epistaxis, sinus congestion, nausea, constipation, dyspepsia, vomiting, diarrhea, hypersalivation, dry mouth, abdominal discomfort, abdominal pain, gastric discomfort, epigastric pain, rash, dry skin, dandruff, seborrheic dermatitis, hyperkeratosis, back pain, arthralgia, limb pain, urinary incontinence, ejaculatory dysfunction, fatigue, asthenia, fever, chest pain, elevated blood creatinine phosphokinase, increased heart rate, pneumonia, soft tissue infection, decreased appetite, confusion, transient ischemic attack, decreased level of consciousness, drooling, cerebrovascular accident, conjunctivitis, hypotension, cough, runny nose, dysphagia, stool impaction, erythema, abnormal posture, joint swelling, peripheral edema, gait disturbance, pitting edema, elevated body temperature, rhinitis, influenza, increased appetite, middle insomnia, lethargy, headache, stuttering, attention deficit, balance disorders, excessive sleep, palpitations, pharyngolaryngeal pain, pulmonary congestion, itching, acne, myalgia, neck pain, nocturnal enuresis, frequency of urination, excessive lactation, emotional disturbances, lethargy, chest discomfort, weight gain, elevated blood prolactin, anxiety, blunted affect, sleep disorders, decreased libido, sexual dysfunction, depression, nightmares, unresponsive to stimuli, coordination disorders, loss of consciousness, speech disorders, sensory deficits, movement disorders, generalized dyskinesia, cerebral ischemia, cerebrovascular accident complications, neuroleptic malignant syndrome, diabetic coma, head tremors, seizures, psychomotor hyperactivity, delayed-onset dyskinesia, cerebrovascular disorders, sensory disturbances, conjunctival congestion, eye discharge, eye movements, eyelid swelling, photophobia, crusting of eyelid margins, ocular dryness, increased tear production, glare, glaucoma, decreased vision, tinnitus, dizziness, bradycardia, tachycardia, palpitations, I-degree atrioventricular block, left bundle branch block, right bundle branch block, atrioventricular block, flushing, conduction disorders, abnormal electrocardiogram, prolonged QT interval on ECG, venous thrombosis, bradycardia, wheezing, aspiration pneumonia, voice disorders, moist cough, airway congestion, rales, respiratory disorder, nasal edema, hyperventilation, fecal incontinence, gastritis, lip swelling, cheilitis, salivary deficiency, abdominal distension, enteritis, tongue swelling, toothache, skin discoloration, skin lesions, dermatological disorders, erythematous rash, papular rash, generalized rash, papulopustular rash, eczema, musculoskeletal chest pain, joint stiffness, muscular weakness, rhabdomyolysis, urination disorders, amenorrhea, gynecomastia, vaginal discharge, erectile dysfunction, ejaculatory disorders, menstrual disorders, breast engorgement, sexual dysfunction, retrograde ejaculation, mammary secretion, thirst, influenza-like syndrome, edema, malaise, facial edema, discomfort, generalized edema, chills, peripheral coldness, drug withdrawal syndrome, adverse drug reactions, decreased body temperature, procedure-related pain, elevated ALT, electrocardiogram abnormalities, increased eosinophils, elevated AST, decreased leukocyte count, elevated blood glucose, decreased hemoglobin, decreased hematocrit, hypothermia, decreased blood pressure, elevated transaminases, increased gamma-glutamyl transferase, elevated liver enzymes, agranulocytosis, thrombocytopenia, abnormal secretion of antidiuretic hormone, diabetic ketoacidosis, diabetes mellitus, hypoglycemia, water intoxication, increased blood cholesterol, increased blood triglycerides, mania, dysgeusia, intraoperative iris hypotension syndrome, atrial fibrillation, deep vein thrombosis, pulmonary embolism, sleep apnea syndrome, intestinal obstruction, pancreatitis, jaundice, vascular edema, hair loss, neonatal drug withdrawal syndrome, urinary retention, priapism, hypothermia, chest pain, abnormal liver function, hepatitis, thirst, dry mouth, urinary retention, polyuria, pain, hiccups, increased sweating, urination disorders, leukopenia, arrhythmia, epistaxis, anemia, diarrhea, hangover, ocular movement seizures, acne, dysphagia, nocturia, tic disorder, dyspnea, Rabbit syndrome, suicide attempts, thought disorder, delusions, hallucinations, exacerbation of symptoms, delayed-onset movement disorders, neuroleptic malignant syndrome, worsening of extrapyramidal symptoms, hyperglycemia, diabetes mellitus, weight gain, falls, priapism, orthostatic hypotension, syncope, decreased core temperature, drowsiness in case of drug overdose, sedation, tachycardia, hypotension, extrapyramidal symptoms, prolonged QT interval, seizures

This medication should be stored in a sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This helps maintain the efficacy of the medication and prevent degradation.

Appearance

Oblong yellow film-coated tablets

Package unit

Domestic use - 30 tablets/bottle, Domestic use - 200 tablets/bottle